Study Affirms Shorter Regimens for Drug-Resistant Tuberculosis

Ireland News News

Study Affirms Shorter Regimens for Drug-Resistant Tuberculosis
Ireland Latest News,Ireland Headlines
  • 📰 Medscape
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 55%

Two short-course bedaquiline-containing treatment regimens for rifampicin-resistant TB showed 'robust evidence' for superior efficacy and less ototoxicity compared to a 9-month injectable control regimen, researchers report. MedTwitter

The 6-month regimen included bedaquiline, clofazimine, pyrazinamide, and levofloxacin for 28 weeks, supplemented by high-dose isoniazid withFor both comparisons, the primary outcome was favorable status at 76 weeks, defined as cultures that were negative forAmong 517 participants in the modified intention-to-treat population across the study groups, 62% were men, and 38% were women .

In the secondary comparison, 69% had a favorable outcome in the control group, compared to 91% of those receiving the 6-month regimen. Exploratory analyses comparing both bedaquiline-containing regimens revealed a significantly higher proportion of favorable outcomes among participants receiving the 6-month regimen compared with patients taking the fully oral 9-month regimen . There were no significant differences in the rate of grade 3 or 4 adverse events.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Ireland Latest News, Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New Study Finds That These Two Diabetes Drugs Perform the BestNew Study Finds That These Two Diabetes Drugs Perform the BestA large-scale clinical trial discovered that two diabetes drugs outperform others. Researchers from the University of Minnesota Medical School contributed to the finding that insulin glargine and liraglutide worked best in a large clinical trial that directly evaluated four drugs frequently used t
Read more »

These companies ran an experiment: Pay workers their full salary to work fewer daysThese companies ran an experiment: Pay workers their full salary to work fewer daysThese U.K. companies ran an experiment: Let employees work 4 days per week without cutting their pay. So far, the feedback is positive: 86% of the companies said they'll likely continue with 4-day weeks.
Read more »

This common pain relief drug causes people to take more risks, study saysThis common pain relief drug causes people to take more risks, study saysA new study claims that a common pain relief drug that people take every day may be driving them to take more risks than usual
Read more »

Northern Ireland faces 'cancer epidemic' without strategy - studyNorthern Ireland faces 'cancer epidemic' without strategy - studyProf Mark Lawler says outcomes for breast cancer patients have gone from the best in the UK to the worst.
Read more »

Sperm Counts Plunge Around the World, Threatening Reproductive Crisis, Study SaysSperm Counts Plunge Around the World, Threatening Reproductive Crisis, Study SaysAnd the rate of decline is accelerating, experts warn.
Read more »

Study suggests Galaxy Watches can help fight obesity through highly accurate biometric readingsStudy suggests Galaxy Watches can help fight obesity through highly accurate biometric readingsA study published by the American Journal of Clinical Nutrition showcases how the biometric reading of the Galaxy Watches was put to the test and the results are very impressive.
Read more »



Render Time: 2025-02-25 20:09:10